SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001085146-24-001015
Filing Date
2024-02-09
Accepted
2024-02-09 18:19:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 CHARLES SCHWAB INVESTMENT MANAGEMENT INC ebs_20824.htm SC 13G 25708
  Complete submission text file 0001085146-24-001015.txt   27353
Mailing Address 211 MAIN STREET SAN FRANCISCO CA 94105
Business Address 211 MAIN STREET SAN FRANCISCO CA 94105 415-627-7000
CHARLES SCHWAB INVESTMENT MANAGEMENT INC (Filed by) CIK: 0000884546 (see all company filings)

IRS No.: 943106735 | State of Incorp.: DE
Type: SC 13G

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Subject) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82602 | Film No.: 24616815
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)